Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on October 22, 2026

Oct. 22, 2026

Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent

Indeterminate GlobeNewswire

Oct. 22, 2026

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility

Indeterminate GlobeNewswire

Oct. 22, 2026

Illume Fertility Continues Its Commitment to LGBTQ+ Family Building at Men Having Babies Chicago Conference

Indeterminate GlobeNewswire

Oct. 22, 2026

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

Indeterminate GlobeNewswire

Oct. 22, 2026

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement

Indeterminate GlobeNewswire

Oct. 22, 2026

Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 22, 2026

Annovis to Attend the CTAD 2026 with Three Presentations

Indeterminate GlobeNewswire

Oct. 22, 2026

Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)

Indeterminate GlobeNewswire

Oct. 22, 2026

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Indeterminate GlobeNewswire

Oct. 22, 2026

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

Oct. 22, 2026

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

Indeterminate GlobeNewswire

Oct. 22, 2026

Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire

Oct. 22, 2026

Solana Company Selected as a Strategic Enterprise by the Hong Kong SAR Government

Indeterminate GlobeNewswire

Oct. 22, 2026

Veterans and Opioid Use Disorder Focus of November Webinar

Indeterminate GlobeNewswire

Oct. 22, 2026

The Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and Webcast

Indeterminate GlobeNewswire